NGT BioPharma Consultants

What NGT BioPharma Consultants does

NGT BioPharma Consultants is a privately-held, Connecticut-based biopharmaceutical consulting firm founded in 2017 by Michael K. O'Brien, PhD, after his tenure as Pfizer's Pharmaceutical Sciences Vice President of Technology & Innovation. The firm delivers strategic, operational, tactical, and transactional advisory across the drug development lifecycle for small molecules, biologics, vaccines, and medical devices, serving international biopharmaceutical companies, biotechs, start-ups, investors, universities, government agencies, and regulatory authorities through a stated portfolio of 100+ clients.

Service delivery is organized around seven integrated practice areas: Nonclinical Sciences, Regulatory Strategies & Submissions, Chemistry Manufacturing & Controls (CMC), Quality & Compliance, Global Supply Chain, Biopharmaceutical Digital Innovation, and Business Development & Due Diligence, supplemented by the Pediatric Center of Excellence niche. The firm's substantive differentiator is the depth of its human capital: a network of 200+ senior consultants and practice leads drawn from Big Pharma R&D leadership, including former executives from Wyeth, Pfizer, Johnson & Johnson, Merck, GSK, Roche, AstraZeneca, and Janssen, with individual leaders typically carrying 30+ years of industry tenure.

The business model is straightforward professional-services delivery: direct enterprise sales, quote-based multi-year engagements, senior-consultant-led project staffing, and no publicly disclosed pricing. Distribution relies on content marketing (case studies and white papers), LinkedIn presence, and senior-level referral networks emanating from ex-employer relationships. Geographic reach is claimed across the USA, UK, Germany, India, Singapore, Switzerland, Brazil, and China. No software product, public-company status, or external funding has been disclosed; the firm is founder-controlled and independent.

Name

NGT BioPharma Consultants

Legal name

NGT BioPharma Consultants LLC

Website

https://ngtbiopharmaconsultants.com

Company type

Private

Founded year

2017

Operating status

Operating

Short description

NGT BioPharma Consultants is a Connecticut-based biopharmaceutical consulting firm founded in 2017 that delivers strategic, operational, and transactional advisory across the drug development lifecycle to pharma, biotech, investor, and regulator clients via a 200+ senior consultant network.

Ownership category

akta.pro rank

Product category

Biopharmaceutical Consulting Services

NAICS

Other Scientific and Technical Consulting Services (54169), Management Consulting Services (54161), Management, Scientific, and Technical Consulting Services (5416)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

CMC, Process Development & Tech Transfer Staffing FSP (HLAGAOAK)

akta.pro secondary industry

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Biopharmaceutical consulting
• Drug development consulting
• CMC consulting
• Regulatory affairs consulting
• Pharmaceutical due diligence

Headquarters

HQ city

East Lyme

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Consulting Services: Professional consulting services across drug development lifecycle including strategic advice, operational services, and transactional support. Services are delivered through tailored engagements matching senior consultants to client needs.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

NGT BioPharma Consultants provides strategic, operational, tactical, and transactional consulting across the drug development lifecycle for small molecules, biologics, vaccines, and medical devices. The firm sells seven interconnected practice areas—Nonclinical Sciences, Regulatory Strategies & Submissions, CMC, Quality & Compliance, Global Supply Chain, Biopharmaceutical Digital Innovation, and Business Development & Due Diligence—delivered by a 200+ person bench of senior industry consultants to biopharma, biotech, investor, academic, and government clients.

Product overview

NGT BioPharma Consultants is a consulting firm offering strategic, operational, tactical, and transactional services across the drug development lifecycle. The firm operates as a unified service portfolio comprising seven interconnected consulting practice areas: Nonclinical Sciences Consulting, Regulatory Strategies & Submissions Consulting, Chemistry Manufacturing & Controls (CMC) Consulting, Quality & Compliance Consulting, Global Supply Chain Consulting, Biopharmaceutical Digital Innovation Consulting, and Business Development & Due Diligence Consulting. These services are delivered by a network of over 200 senior consultants and serve a diverse clientele including international biopharmaceutical companies, biotechs, start-ups, investors, universities, government agencies, and regulatory authorities. The company does not offer a software product but provides consulting expertise spanning late-stage discovery through preclinical and clinical development, regulatory approval, commercialization, and product lifecycle management for small molecules, biologics, vaccines, and medical devices.

Differentiator

Problem solved

Functional benefit

Products and services

• Nonclinical Sciences Consulting Consulting services supporting nonclinical strategies, pharmacology, toxicology studies, PK/PD evaluation, and IND-enabling toxicology for biopharmaceutical sponsors advancing drug candidates into first-in-human clinical trials.
• Regulatory Strategies & Submissions Consulting Comprehensive regulatory strategy services including IND/CTA support, NDA/BLA/MAA dossier authoring, expedited program requests (Breakthrough, Fast Track, Priority Review), and management of health authority interactions throughout the product lifecycle.
• Chemistry, Manufacturing & Controls (CMC) Consulting CMC services spanning early and late-stage development for small molecules and biologics, covering API development, drug product formulation, analytical methods, scale-up, commercial manufacturing strategy, and regulatory submissions for drug substance and drug product.
• Quality & Compliance Consulting Full-service GXP Quality Assurance, regulatory inspection readiness, pharmaceutical quality system strategy and implementation, GXP documentation development, supplier qualification, and validation/qualification services for facilities, utilities, equipment, methods, and computer systems.
• Global Supply Chain Consulting Strategic, tactical, and operational supply chain consulting including supply chain strategy development, vendor selection, ERP system implementation, demand and supply planning, inventory optimization, and operational excellence methodologies for clinical and commercial supply.
• Biopharmaceutical Digital Innovation Consulting Digital transformation services for biopharmaceutical companies including staff augmentation with digital experts, software development and marketing consultancy, and digital strategy advisory to enhance R&D and manufacturing workflows through cloud systems, IoT, digital twins, and AI/ML integration.
• Business Development & Due Diligence Consulting Business development strategy and transactional support including end-to-end BD expertise, technical due diligence for buy-side and sell-side transactions, valuation, negotiation, deal execution, and alliance management for licensing, collaboration, and M&A activities.

Quantifiable outcome

• Collaborated with over 100 clients across all industry sectors
• +3 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Trinity Life Sciences: Life sciences strategic consulting firm providing evidence-based strategy and insights to biopharma across commercial, R&D, and medical affairs. Direct comparable to NGT in target client (biopharma leadership) and high-end advisory business model.
• Clearview Healthcare Partners: Boutique life sciences strategy consulting firm serving biotech and pharma on commercial strategy, R&D, and due diligence. Closest direct comparable to NGT's BD/Due Diligence and strategic advisory practices.
• Health Advances: Healthcare and life sciences consulting firm advising on strategy, due diligence, and product development for biopharma and medtech. Directly comparable to NGT's biotech/investor advisory and drug development practices.
• Lumanity: Life sciences consulting firm formed from the merger of inVentiv Health Consulting, GSW Worldwide, and several other advisory brands. Comparable to NGT in serving biopharma with strategic, medical, and commercial advisory.
• Back Bay Life Science Advisors: Boston-based boutique advisory firm focused on life sciences M&A, strategic partnering, and royalty/financing transactions. Closely comparable to NGT's BD/Due Diligence practice for biotechs and investors.

Broad incumbents

• ZS Associates: Global consulting firm with a major biopharma practice covering strategy, R&D operations, and commercial. Comparable to NGT in pharma client base and senior-advisory model, but far broader scope and scale.
• IQVIA: World's largest CRO with extensive consulting, real-world evidence, and technology solutions serving pharma across the full lifecycle. Competes with NGT in regulatory/CMC/strategy work, but at vastly larger scale and broader service scope.
• Charles River Laboratories: Major CRO/CDMO with biopharma discovery, safety assessment, and manufacturing services. Adjacent competitor to NGT on the operational side of drug development (CMC, nonclinical) where senior consulting engagements often overlap.
• Parexel International: Global CRO providing clinical research, regulatory, and consulting services to biopharma. Overlaps with NGT on regulatory strategy and CMC consulting, but at significantly larger scale.
• McKinsey & Company (Pharma Practice): Top-tier management consultancy with deep pharma and biotech practice covering R&D productivity, due diligence, and operating model. Often competes with NGT for high-level strategic advisory at large biopharma clients.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ngtbiopharmaconsultants

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NGT BioPharma Consultants